Effect of zoledronic acid on fracture healing in osteoporotic patients with intertrochanteric fractures.

Aims: To assess the effect of zoledronic acid (ZOL) on fracture healing in osteoporotic patients with intertrochanteric fracture based on radiological evaluation and to study the correlations between severity of osteoporosis, age, gender, and time taken to fracture union.

Settings And Design: An open label study was conducted on 43 patients at a tertiary care center.

Subjects And Methods: The osteoporosis status of all the included patients was documented using a double-energy X-ray absorptiometry scan.

A Study on the Correlation of Pertrochanteric Osteoporotic Fracture Severity with the Severity of Osteoporosis.

Introduction: Osteoporosis is a metabolic bone disease caused by progressive bone loss. It is characterized by low Bone Mineral Density (BMD) and structural deterioration of bone tissue leading to bone fragility and increased risk of fractures. When classifying a fracture, high reliability and validity are crucial for successful treatment.